Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04723095 · ClinicalTrials.gov registry record
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
A clinical trial of Cervical Small Cell Carcinoma and Cervical Large Cell Neuroendocrine Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT04723095 is a study of Cervical Small Cell Carcinoma and Cervical Large Cell Neuroendocrine Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 750 participants, above the 43-participant average among 3 other Cervical Small Cell Carcinoma trials with a reported enrollment target (1644% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04723095, a study of Cervical Small Cell Carcinoma and Cervical Large Cell Neuroendocrine Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Conditions Studied
Interventions
- OTHER Medical Chart Review
- OTHER Follow-Up
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2013-05-16 |
| Est. Completion | 2044-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04723095
The ClinicalTrials.gov registry entry for NCT04723095 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 43-participant average among 3 other Cervical Small Cell Carcinoma trials with a reported enrollment target (1644% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Cervical Small Cell Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT04723095 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04723095 about?
NCT04723095 is a clinical study titled "Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix". This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
What is the current status of trial NCT04723095?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2013-05-16. Estimated completion is 2044-01-01.
What conditions does trial NCT04723095 study?
This clinical trial studies the following conditions: Cervical Small Cell Carcinoma, Cervical Large Cell Neuroendocrine Carcinoma, Cervical Neuroendocrine Carcinoma, Cervical Undifferentiated Carcinoma, Stage I Cervical Cancer AJCC v8.
What interventions are being tested in trial NCT04723095?
The interventions under investigation include: Medical Chart Review (OTHER), Follow-Up (OTHER).
Who is sponsoring clinical trial NCT04723095?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04723095 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Small Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
COMPLETED · Phase 2
-
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
COMPLETED · Phase 2
-
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
COMPLETED · Phase 1
Explore more on PlainTrial
Cervical Small Cell Carcinoma
All registered trials for this condition
Cervical Large Cell Neuroendocrine Carcinoma
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.